Type IA variation for application ANVISA-2020-0025. Type IA variation: Analytical Method Change for Tisagenlecleux-B — minor update

Variation Number
ANVISA-2020-0025-V025
Type
Type IA
Application
Status
In Progress
Fee
€4,908
Submitted
—
Approved
—
Description

Type IA variation: Analytical Method Change for Tisagenlecleux-B — minor update